Award

Ruma Banerjee honored
for discoveries in vitamin B12
and H2S signaling

Dawn Hayward
April 1, 2019

The complicated makeup and chemistry of the cofactor vitamin B12 have intrigued researchers for decades. Ruma Banerjee, Vincent Massey collegiate professor and associate chair of biological chemistry at the University of Michigan, has unraveled much of the mystery behind this vitamin, including transport to other proteins and the kinetics of a related sulfur signaling pathway. For her work, she has won the American Society for Biochemistry and Molecular Biology’s 2019 ASBMB–Merck Award.

Ruma Banerjee “I saw that Natalie Ahn was calling and wondered what ASBMB committee she was going to ask me to serve on. I was floored when I realized she was calling about the Merck award!”
— Ruma Banerjee

Also known as cobalamin, vitamin B12 is a cofactor for two mammalian enzymes, but how the cobalt atom is prepped to reach its final destinations had eluded researchers. Banerjee’s laboratory discovered dual functionalities for a protein, CblC, that partitions cobalamin to the cytoplasm and the mitochondrion to generate methionine and succinyl-CoA, respectively.

In the mitochondrion, cobalamin is transferred to the active site of a different enzyme to generate succinyl-CoA from methyl-CoA. Inactivating the enzyme, however, can lead to buildup of a radical. Banerjee showed that turnover can be regulated by the substrate to prevent high radical levels. Collaborating with Catherine Drennan at the Massachusetts Institute of Technology, Banerjee determined the crystal structure of the chaperone in this process.

Banerjee investigated hydrogen sulfide production where substrate homocysteine is used in the methionine arm of vitamin B12 chemistry. Cystathionine beta-synthase, or CBS, produces H2S along with cystathionine. Banerjee determined the specific residues in CBS that differentiate these functions and identified a metabolic switch whereby iron helps determine activity.

Her University of Michigan colleague James Bardwell, who nominated Banerjee for the award, wrote in his nomination letter, “This insight explains why previous clinical trials for lowering homocysteine have failed to increase cardiovascular disease burden and suggests … that a strategy for modulating H2S might be effective instead.”

Banerjee received her bachelor’s and master’s degrees from Delhi University in India and her Ph.D. in biochemistry from the Rensselaer Polytechnic Institute in New York and was a postdoctoral fellow in biophysics at the University of Michigan. She served on the faculty at the University of Nebraska-Lincoln before moving back to the University of Michigan.

Banerjee is an associate editor for Chemical Reviews and the Journal of Biological Chemistry. She also has chaired and started two new sections for the Gordon Research Conference. Squire J. Booker, a professor at Pennsylvania State University, wrote in his letter supporting the nomination, “She cares deeply about our scientific discipline, and gives of her time unselfishly to make it better.”

Banerjee has authored more than 230 publications. She received the Pfizer award early in her career, and this is noteworthy, according to Judith P. Klinman, a professor at the University of California, Berkeley, because the Pfizer “has been a very significant predictor of future advances by the awardee. Her progress and contributions have confirmed this expectation.”

Banerjee will receive her award at the ASBMB annual meeting during the Experimental Biology 2019 conference in Orlando, where she will deliver an award lecture titled “Signaling through sulfide” at 8 a.m. April 9 in Valencia Ballroom A at the Orange County Convention Center.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Dawn Hayward

Dawn Hayward earned a Ph.D. in biochemistry from the Johns Hopkins University School of Medicine

Related articles

Out with the old, in with the nucleus
Glen Liszczak & Aaron Johnson
Translating the glycosylation code
Laura Elyse McCormick
Targeting cardiolipin modification in a genetic disorder
Arianna F. Anzmann, Olivia Sniezek & Hilary Vernon
Varghese roams from forests to enzymes
Guananí Gómez–Van Cortright

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Meet Sarah O’Connor
Interview

Meet Sarah O’Connor

Sept. 21, 2023

This JBC associate editor scouts the plant kingdom for intriguing pathways and hits the hiking trails in Germany.

Shedding light on Usher syndrome
Health Observance

Shedding light on Usher syndrome

Sept. 16, 2023

On this awareness day, learn about the most common cause of genetic deaf–blindness and those it affects.

Top-notch papers by postdocs
Observance

Top-notch papers by postdocs

Sept. 15, 2023

During National Postdoc Appreciation Week, learn about the postdoc first authors of the most-read papers in ASBMB’s journals.

Completing the cycle of genomic medicine
Health Observance

Completing the cycle of genomic medicine

Sept. 11, 2023

Wolfgang Pernice is both a patient with and a researcher of Charcot‒Marie‒Tooth disease.

Honors for Nogales, Marqusee, Cohen and Hobbs
Member News

Honors for Nogales, Marqusee, Cohen and Hobbs

Sept. 4, 2023

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

In memoriam: Henry Bourne
In Memoriam

In memoriam: Henry Bourne

Sept. 4, 2023

He was a professor at UC San Francisco for four decades focusing his research on the role of G proteins in cell signaling and disease, and an ASBMB member for almost 30 years.